EMG Holdings’s Envoy Medical COCH Stock Holding History

EMG Holdings’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-222,741	Closed	-$2.18M	–	255
2022 Q1	$2.18M	Sell	222,741 -89,962	-29%	-$875K	0.18%	73
2021 Q4	$3.04M	Buy	+312,703	New	+$3.05M	0.39%	51

Other funds holding COCH

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

DAM

DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EMG Holdings's COCH Position: Q2 2022 in Review

EMG Holdings sold out of Envoy Medical (COCH) in Q2 2022, closing a stake of 222,741 shares — an estimated $2.18M sold.

EMG Holdings first reported a position in COCH in Q4 2021 and held it in 2 quarters. The position peaked at $3.04M in Q4 2021. 89 funds tracked by Wall St. Rank hold COCH as of Q2 2022.

EMG Holdings reported no remaining Envoy Medical position as of Q2 2022 after selling out during the quarter.
EMG Holdings sold 222,741 Envoy Medical shares in Q2 2022, an estimated $2.18M.
EMG Holdings first reported a position in Envoy Medical in Q4 2021 and held it in 2 quarters.
EMG Holdings's Envoy Medical position peaked at $3.04M in Q4 2021.
89 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2022.

Based on EMG Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.